283 studies found for:    Exclude Unknown | Expanded Access Studies
Show Display Options
Download search resultsDownload the search results for:
Exclude Unknown | Expanded Access Studies (283 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Available Expanded Access for Single Patient Treatment of Autologous Human Schwann Cells (ahSC) for Peripheral Nerve Repair
Condition: Sciatic Nerve Injury
Intervention: Biological: Autologous Human Schwann cells
2 Temporarily not available Early Access Treatment With Daratumumab for (Relapsed or Refractory) Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Daratumumab
3 Available Expanded Access Program With Nivolumab Monotherapy for Treatment of Advanced/Metastatic SqNSCLC After One Prior Systemic Regimen
Condition: Non-Small Cell Lung Cancer
Intervention: Drug: Nivolumab
4 Temporarily not available Safety and Efficacy of Autologous Concentrated Bone Marrow Aspirate for Critical Limb Ischemia - Continued Access
Conditions: Peripheral Arterial Disease;   Peripheral Vascular Diseases;   Critical Limb Ischemia
Intervention: Device: Bone marrow concentration device
5 Available Pilot Trial of HER-2/Neu Pulsed DC1 Vaccine for Patients With HER-2 Positive Metastatic Cancer
Condition: Metastatic Cancer
Intervention: Biological: HER-2/neu Pulsed DC1 vaccine
6 Temporarily not available Crizotinib (Xalkori) Expanded Access Protocol For The Treatment Of Adult Or Pediatric Patients
Condition: Neoplasm
Intervention: Drug: Crizotinib
7 Available Treatment of Drug Resistant Epilepsy
Condition: Epilepsy
Interventions: Drug: Epidiolex®;   Other: Blood Test
8 Available AZD9291 US Expanded Access Program
Condition: EGFR T790M Mutation Positive NSCLC
Intervention: Drug: AZD9291
9 Temporarily not available Early Access Program (EAP) for Ibrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Condition: B-cell Chronic Lymphocytic Leukemia
Intervention: Drug: PCI-32765 (Ibrutinib)
10 Temporarily not available HAIC Using Oxaliplatin Plus Fluorouracil/Leucovorin for Patients With Locally Advanced HCC
Conditions: Hepatocellular Carcinoma;   Injury; Blood Vessel, Hepatic, Artery
Interventions: Procedure: HAIC using oxaliplatin plus fluorouracil/leucovorin;   Drug: Oxaliplatin;   Drug: Fluorouracil;   Drug: Leucovorin
11 Available HUD: PIP Joint Implant
Conditions: Arthrosis;   Osteoarthrosis
Intervention: Device: SR PIP Implant System
12 Available An Open Label, Expanded Access Protocol With SAGE-547 for Super-Refractory Status Epilepticus
Condition: Super-Refractory Status Epilepticus
Intervention: Drug: SAGE-547
13 Available [18 F]-6-L-fluorodihydroxyphenylalanine (18F-FDOPA) Positron Emission Tomography (PET) in Neuroendocrine Tumours
Conditions: Thyroid Cancer, Medullary;   Carcinoid Tumor;   Pheochromocytoma;   Paraganglioma;   Insulinoma;   Neuroblastoma
Intervention: Drug: [18 F]-6-L-fluorodihydroxyphenylalanine (18F-FDOPA)
14 No longer available Use of the Zenith® Dissection Endovascular System to Treat Patients With Acute, Complicated Type B Aortic Dissection
Condition: Aortic Dissection
Intervention: Device: Zenith® Dissection Endovascular System
15 Available SMOF Lipid for Children With Parenteral Nutrition Induced Liver Injury
Conditions: Cholestasis;   Growth Failure
Intervention: Drug: SMOFlipid
16 Temporarily not available Expanded Access Study for Renal Transplant Patients With Envarsus XR ™
Condition: Renal Failure
Intervention: Drug: Tacrolimus
17 Available Epidiolex and Drug Resistant Epilepsy in Children
Condition: Epilepsy
Intervention: Drug: Cannabidiol (Epidiolex)
18 Available Multiple Patient Program to Ensure Access to LCZ696 Treatment to Patients Diagnosed With Heart Failure With Reduced Ejection Fraction (HF-rEF)
Condition: Heart Failure With Reduced Ejection Fraction
Intervention: Drug: LCZ696
19 Temporarily not available Compassionate Treatment : An Exploratory Clinical Trial to Assess Treatment of Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Intervention: Procedure: Autologous Adipose-Tissue Derived Stem Cells
20 Available An Expanded Access Protocol for Sebelipase Alfa for Patients With Lysosomal Acid Lipase Deficiency
Condition: Lysosomal Acid Lipase Deficiency
Intervention: Drug: sebelipase alfa

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years